Lonazolac

{{Short description|Chemical compound}}

{{Drugbox

| Verifiedfields = changed

| Watchedfields = changed

| verifiedrevid = 447986412

| IUPAC_name = [3-(4-chlorophenyl)-1-phenyl-1H-pyrazol-4-yl]acetic acid

| image = lonazolac.png

| image_class = skin-invert-image

| tradename =

| pregnancy_AU =

| pregnancy_US =

| pregnancy_category =

| legal_AU =

| legal_CA =

| legal_UK =

| legal_US =

| legal_status =

| routes_of_administration =

| bioavailability =

| protein_bound =

| metabolism =

| elimination_half-life =

| excretion =

| CAS_number_Ref = {{cascite|correct|CAS}}

| CAS_number = 53808-88-1

| ATC_prefix = M01

| ATC_suffix = AB09

| PubChem = 68706

| DrugBank_Ref = {{drugbankcite|correct|drugbank}}

| DrugBank =

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = 13097143QI

| KEGG_Ref = {{keggcite|correct|kegg}}

| KEGG = D07265

| ChEBI_Ref = {{ebicite|changed|EBI}}

| ChEBI = 76164

| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}

| ChemSpiderID = 61957

| C=17 | H=13 | Cl=1 | N=2 | O=2

| smiles = c1ccc(cc1)n2cc(c(n2)c3ccc(cc3)Cl)CC(=O)O

| StdInChI_Ref = {{stdinchicite|changed|chemspider}}

| StdInChI = 1S/C17H13ClN2O2/c18-14-8-6-12(7-9-14)17-13(10-16(21)22)11-20(19-17)15-4-2-1-3-5-15/h1-9,11H,10H2,(H,21,22)

| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}

| StdInChIKey = XVUQHFRQHBLHQD-UHFFFAOYSA-N

}}

Lonazolac is a nonsteroidal anti-inflammatory drug (NSAID).